Immediate Impact

61 standout
Sub-graph 1 of 23

Citing Papers

NF-κB in biology and targeted therapy: new insights and translational implications
2024 Standout
Non-small-cell lung cancer
2024 Standout
2 intermediate papers

Works of Sujith Kalmadi being referenced

Daily Subcutaneous Amifostine Facilitates Radiation Dose Escalation for Poor Risk Unresectable Stage III Lung Cancer
2007
Phase I trial of three-weekly Docetaxel, Carboplatin and oral lenalidomide (Revlimid®) in patients with advanced solid tumors
2006

Author Peers

Author Last Decade Papers Cites
Sujith Kalmadi 133 99 44 145 26 399
Michelle E A Borm 134 68 52 60 25 447
Mariangela Rutigliani 101 67 36 47 31 452
C. Bernard 156 80 88 76 19 436
Ahmad Iftikhar 91 40 31 100 31 372
Jung Yeon Lee 62 49 30 131 26 453
Mary‐Anne Kedda 142 90 29 49 22 451
Chang‐Suk Kang 79 40 28 83 27 363
Song Wang 85 39 28 69 34 397
Harald E. Fischer 93 31 19 82 21 425
Anne Nihtinen 99 25 14 106 24 365

All Works

Loading papers...

Rankless by CCL
2026